This dual activation is crucial for an effective anti-tumor immune response, as CD8+ T cells are responsible for directly killing cancer cells [22], while CD4+ T cells support the proliferation and activation of CD8+ T cells and B cells [23]. The gene discussed is CD8A; the disease is neoplasm.